AleAnna (ANNA) Q2 2024 earnings summary

Executive summary

• Blank check company focused on completing a business combination; no operating revenues to date, only interest income from trust account investments.

• Entered into a new merger agreement with AleAnna Energy, LLC on June 4, 2024, after terminating a prior agreement with HDL Therapeutics.

• Shareholder approval obtained to extend the deadline for a business combination to June 17, 2025; significant redemptions have reduced trust account funds.

Financial highlights

• Net loss of $355,510 for Q2 2024, compared to net income of $1,472,815 in Q2 2023.

• Net loss of $446,579 for the six months ended June 30, 2024, versus net income of $2,583,055 for the same period in 2023.

• Interest income from trust account investments was $173,957 for Q2 2024 and $483,863 for the six months ended June 30, 2024.

• Cash held outside the trust account was $2,633 as of June 30, 2024; trust account balance was $13.5 million.

• 1,031,997 Class A shares redeemed in March 2024 for $11.3 million; 4,589,913 Class A shares outstanding as of August 28, 2024.

Outlook and guidance

• Must complete a business combination by June 17, 2025, or face mandatory liquidation.

• Management expresses substantial doubt about the ability to continue as a going concern due to limited liquidity and no confirmed financing commitments.

• Plans to address liquidity through a business combination or further extension, but success is not assured.